Biotechnology News

July 2, 2012

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero...

July 2, 2012

NO. BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced the publication of the results from the CaRES multicenter...

July 2, 2012

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical company specializing in oncology, today announced that the European Patent Office (EPO) has issued a patent covering the Company’s tumor-targeting linker platform...

July 2, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today announced that it has amended its license...

July 2, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Robert J. Perez, currently Executive Vice President and Chief Operating Officer (COO), has been named President and COO, and Michael Tomsicek,...

July 2, 2012

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), announced today interim one-year results from its groundbreaking clinical trial evaluating Prochymal® (remestemcel-L) for the treatment of patients experiencing first-time...

July 2, 2012

SAN ANTONIO--(BUSINESS WIRE)--Mike Mathews Named Senior Vice President, International at KCI; Mathews to Lead Commercial Business Activities in International Markets

July 2, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted an...

July 2, 2012

NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX), an international manufacturer and marketer of pharmaceutical products, will release its Fiscal 2013 First Quarter financial results before the U.S. stock market opens on Tuesday,...

July 2, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics completes $3,000,000 private placement with its strategic partner Delta Dental Plan of Michigan to advance genetic testing services

July 2, 2012

MENLO PARK, Calif.--(BUSINESS WIRE)--Two papers in Nature Biotechnology, both published online on July 1, 2012 highlight the unique value for de novo genome assembly provided by the PacBio® RS High Resolution Genetic Analyzer.

July 2, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen announced the development of "NexGen," a new platform designed to significantly enhance Compugen’s overall infrastructure for predictive drug and drug target discovery.

July 2, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--Natus Medical Incorporated (Nasdaq:BABY) today announced that it has completed the acquisition of the Nicolet neurodiagnostic business from CareFusion (NYSE: CFN) that was announced on April 23, 2012. Based in...

July 2, 2012

LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Receives FDA 510(k) Clearance for CVP Monitoring Indication on the ArrowADVANTAGE Pressure-Injectable PICC

July 2, 2012

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Jonathan S. Jaffe MD to the position of Vice President of Clinical Development. Jonathan’s background includes a 12 year post-graduate career in...

July 2, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurological injuries, today announced a novel hydrogel based...

July 2, 2012

COLD SPRING HARBOR, N.Y.--(BUSINESS WIRE)--The next “next-gen” technology in genome sequencing has gotten a major boost. Researchers at CSHL have fixed a serious problem in the newest genome sequencing technology: an error rate as high as 20%

July 2, 2012

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Ibandronate Sodium tablets (150 mg), a bioequivalent generic version of BONIVA ® tablets in the US market on June 29, 2012 following the...

July 2, 2012

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: Orexo AB (“Orexo”) has ahead of schedule completed a crucial comparative bioavailability study for its product OX219. The market in the US alone for this type of treatment for people addicted to...

July 2, 2012

TOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ: 4573) has announced that it has been notified by the International Court of Arbitration, International Chamber of Commerce (ICC), that the date of the deadline for rendering the arbitration decision...

June 30, 2012

PRINCETON, N.J., LONDON, & SAN DIEGO--(BUSINESS WIRE)--Bristol-Myers Squibb and AstraZeneca Expand Diabetes Alliance Through Bristol-Myers Squibb’s Acquisition of Amylin Pharmaceuticals

June 29, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today the presentation of clinical results for its biologic oncology candidates, lipegfilgrastim and balugrastim, at the Multinational Association of...

June 29, 2012

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo reported that the ICC has notified the Company of a change in the anticipated date of the decision related to the Company's demand for arbitration from June 29, 2012 to July 31, 2012.

June 29, 2012

DENVER--(BUSINESS WIRE)--Quoting New Battelle/BIO Report: "Colorado’s bioscience industry is large and has outpaced national growth since 2001 by continuing to add jobs overall since 2007."

June 29, 2012

LIEGE, BELGIUM--(BUSINESS WIRE)--MDxHealth successfully raises EUR10 million

June 29, 2012

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: The number of shares and votes in Orexo (STO:ORX) has changed as a result of the exercise of warrants. Today, the last trading day of the month, there are in total 29,899,993 shares and votes in...

June 29, 2012

LONDON--(BUSINESS WIRE)--New market study on Biosimilars in Emerging Economies developed by GBI Research has beenr ecently published by Market Publishers Ltd.

June 29, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife has entered into an agreement to acquire Cryo Management Ltd, one of the world’s leading players within time-lapse for IVF, developer of Primo Vision time-lapse embryo monitoring...

June 29, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Human Genome Sciences, Inc. (Nasdaq: HGSI) today issued the following statement regarding the extension by GlaxoSmithKline plc (GSK) of its unsolicited tender offer to acquire all the outstanding common shares of...

June 29, 2012

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2012 financial results on Tuesday, August 7th, after the market closes. A conference call has been scheduled to discuss...

June 29, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) (the “Company”) today announced that Arthur A. Koch, the Company’s Executive Vice President, Finance, and Chief Financial Officer, has informed the Company of his decision...

June 29, 2012

WESTON, Mass. & CARLSBAD, Calif.--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) and Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) today announced that they have entered into an exclusive, worldwide option and collaboration agreement under which the...

June 29, 2012

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), announced today the expansion of its intellectual property protection around Prochymal® (remestemcel-L). The United States Patent and Trademark Office recently granted...

June 29, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma today announced additional data from the Company’s Phase 3 study of APF530 for the prevention of chemotherapy-induced nausea and vomiting (CINV).

June 29, 2012

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricies, Inc. raises $5M in registered shelf offering.

June 29, 2012

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine (STO:AEROB): With reference to Chapter 4 Section 9 in ”lagen (1991:980) om handel med finansiella instrument” it’s hereby announced that through the subscription by exercise of options in...

June 29, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Paris:IPN) (Euronext: IPN; ADR: IPSEY) announced today that its partner Teijin has received manufacturing and marketing approval from the Japan’s Ministry of Health, Labour and Welfare (MHLW) for...

June 29, 2012

SINGAPORE--(BUSINESS WIRE)--Dow Water & Process Solutions, a business unit of The Dow Chemical Company (NYSE: DOW), will participate in Singapore International Water Week (SIWW) at Sands Expo and Convention Centre from July 2nd – 4th, 2012....

June 28, 2012

NEW YORK--(BUSINESS WIRE)--The board of directors of Pfizer Inc. (NYSE: PFE) today declared a 22-cent third-quarter 2012 dividend on the company’s common stock, payable September 5, 2012, to shareholders of record at the close of business on...

June 28, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for marketing approval of cobicistat, a pharmacoenhancing or “...

June 28, 2012

SAN BRUNO, Calif.--(BUSINESS WIRE)--Numerate, Inc., which is transforming the drug discovery process through the use of cloud computing and proprietary algorithms, is one of several companies to use the new Google Compute Engine.

June 28, 2012

EATONTOWN, N.J.--(BUSINESS WIRE)--Flexible Stenting Solutions, Inc. (“FSS”), a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today that it has extended its CE Mark authorized family...

June 28, 2012

PHILADELPHIA--(BUSINESS WIRE)--Today’s Supreme Court decision came during the DIA 2012 Annual Meeting CDER Town Hall—generating mixed reaction from the 600 people in attendance.

June 28, 2012

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Medical calls for the U.S. Senate to repeal the 2.3 percent medical device excise tax

June 28, 2012

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo announced that Silvia Taylor has joined as Senior Vice President, Investor Relations, Public Relations and Corporate Communications.

June 28, 2012

WASHINGTON--(BUSINESS WIRE)--BIO President and CEO has released a statement on the ruling issued today by the U.S. Supreme Court regarding the Affordable Care Act.